Sign inJoin waitlistJoin the waitlist

MF

Marc Feinberg

Physician · South Florida Neurology Associates Pa

Credentials: · · ·

History

South Florida Neurology Associates Pa
Present

Rheumatology
1995–1997
Neurology
1991–1995
Doctor of Medicine
1987–1991

Research

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase…
The Lancet Neurology · 2023 · 236 citations
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial
Nature Medicine · 2026 · 14 citations
Durability of Response to B-Cell Maturation Antigen-Directed mRNA Cell Therapy in Myasthenia Gravis
Annals of Clinical and Translational Neurology · 2025 · 14 citations

Gregory Sahagian
3 papers
James Howard
3 papers
MK
Metin Kurtoglu
3 papers
TM
Tahseen Mozaffar
3 papers
Tuan Vu
3 papers
MK
Murat Kalayoglu
2 papers
NC
Nizar Chahin
2 papers
AS
Adam Slansky
1 paper
Amanda Peltier
1 paper
BM
Bennett Myers
1 paper
Chafic Karam
1 paper
George Small
1 paper

Clinical trials

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2033
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Site PI · Recruiting · Phase 3
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
2024–2030
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Site PI · Recruiting · Phase 2
NMD Pharma A/S
2024–2026